SIMILAR PATTERNS OF AMINO ACIDS FOR 5T0M_A_SAMA1205_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 5 | TRP A 161ASN A 241HIS A 242TYR A 283CYH A 308 | SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 (-2.2A) | 1.23A | 5t0mA-1pegA:26.0 | 5t0mA-1pegA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | TRP A 161TYR A 204ASN A 241HIS A 242TYR A 283CYH A 306 | SAH A 319 (-4.8A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) | 0.48A | 5t0mA-1pegA:26.0 | 5t0mA-1pegA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | TRP A 152TYR A 193ASN A 219HIS A 220TYR A 261CYH A 287 | NoneSAM A 304 (-4.2A)SAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 0.41A | 5t0mA-2r3aA:28.4 | 5t0mA-2r3aA:34.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | ASN A3906HIS A3907TYR A3944PHE A3946CYH A3957 | SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A)None ZN A4970 ( 2.3A) | 0.80A | 5t0mA-2w5zA:12.3 | 5t0mA-2w5zA:27.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | SER A 176TYR A 178HIS A 210TYR A 248CYH A 273 | SAH A 305 ( 3.7A)SAH A 305 (-4.0A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.29A | 5t0mA-3bo5A:26.5 | 5t0mA-3bo5A:33.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | TRP A 137ASN A 209HIS A 210TYR A 248PHE A 286LYS A 271 | NoneSAH A 305 (-3.4A)NoneSAH A 305 (-4.9A)SAH A 305 (-4.9A)SAH A 305 ( 4.1A) | 0.94A | 5t0mA-3bo5A:26.5 | 5t0mA-3bo5A:33.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | TRP A 137TYR A 178ASN A 209HIS A 210TYR A 248PHE A 286CYH A 273 | NoneSAH A 305 (-4.0A)SAH A 305 (-3.4A)NoneSAH A 305 (-4.9A)SAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 0.57A | 5t0mA-3bo5A:26.5 | 5t0mA-3bo5A:33.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | TRP A 103ASN A 169HIS A 170TYR A 207CYH A 221 | NoneSAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 (-2.3A) | 1.08A | 5t0mA-3ooiA:19.5 | 5t0mA-3ooiA:30.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 6 | TRP A 103TYR A 146ASN A 169HIS A 170TYR A 207CYH A 219 | NoneSAM A 237 (-4.1A)SAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A) | 0.30A | 5t0mA-3ooiA:19.5 | 5t0mA-3ooiA:30.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | TRP A2152ASN A2217HIS A2218TYR A2255CYH A2270 | NoneSAM A 7 (-3.9A)NoneNone ZN A 1 (-2.7A) | 1.05A | 5t0mA-3opeA:17.8 | 5t0mA-3opeA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 6 | TRP A2152TYR A2194ASN A2217HIS A2218TYR A2255CYH A2268 | NoneSAM A 7 (-3.4A)SAM A 7 (-3.9A)NoneNone ZN A 1 ( 2.5A) | 0.39A | 5t0mA-3opeA:17.8 | 5t0mA-3opeA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4au7 | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H2 (Mus musculus) |
PF00856(SET) | 5 | ASN A 182HIS A 183TYR A 217PHE A 221CYH A 229 | SAH A1247 (-3.1A)SAH A1247 (-4.6A)NoneNone ZN A1248 ( 2.3A) | 0.65A | 5t0mA-4au7A:8.4 | 5t0mA-4au7A:22.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 5 | TRP A1562TYR A1605ASN A1628HIS A1629CYH A1678 | None0UM A1804 (-4.2A)0UM A1804 (-3.3A)None ZN A1803 ( 2.2A) | 0.26A | 5t0mA-4fmuA:18.5 | 5t0mA-4fmuA:28.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 6 | TRP A 458TYR A 493ASN A 551HIS A 552TYR A 593CYH A 612 | SAH A 801 (-4.9A)SAH A 801 (-4.0A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) | 0.54A | 5t0mA-4qeoA:29.5 | 5t0mA-4qeoA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 5 | TYR A5451ASN A5474HIS A5475TYR A5512CYH A5525 | SAH A5602 (-4.5A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) | 0.49A | 5t0mA-4z4pA:13.7 | 5t0mA-4z4pA:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 5 | TYR A4825ASN A4848HIS A4849TYR A4886CYH A4899 | SAH A5002 (-4.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) | 0.71A | 5t0mA-5f59A:13.4 | 5t0mA-5f59A:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 5 | ASN A3906HIS A3907TYR A3944PHE A3946CYH A3957 | SAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A)None ZN A4002 ( 2.3A) | 0.80A | 5t0mA-5f6lA:13.4 | 5t0mA-5f6lA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 5 | TYR A3883ASN A3906HIS A3907TYR A3944CYH A3957 | NoneSAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) | 0.55A | 5t0mA-5f6lA:13.4 | 5t0mA-5f6lA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 6 | TRP A1075TYR A1118ASN A1141HIS A1142TYR A1179CYH A1191 | NoneSAM A1304 (-3.8A)SAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) | 0.19A | 5t0mA-5lsuA:20.3 | 5t0mA-5lsuA:27.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 12 | MET A1048TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.43A | 5t0mA-5tuyA:41.1 | 5t0mA-5tuyA:99.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ukh | UNCHARACTERIZEDPROTEIN (Streptococcusintermedius) |
no annotation | 5 | MET A 479SER A 406TYR A 236PHE A 402GLN A 476 | None | 1.38A | 5t0mA-5ukhA:undetectable | 5t0mA-5ukhA:19.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 11 | MET A1136TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.57A | 5t0mA-5vsdA:40.0 | 5t0mA-5vsdA:77.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 6 | TRP A1157TYR A1200ASN A1223HIS A1224TYR A1261CYH A1273 | NoneSAM A1301 (-3.9A)SAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) | 0.25A | 5t0mA-6cenA:19.9 | 5t0mA-6cenA:28.81 |